Search Within

Joachim Yahalom

  1. "CTCR Scholars"
Formats
  1. Meeting Abstract (45)
  2. Journal Article (15)
  3. Research Letter (2)
Groups
  1. CTCR Scholars (62)
  2. Center for Hematologic Malignancies (62)
  3. Department of Medicine (62)
  4. Hematologic Malignancies, Division of (62)
  5. Radiation Oncology, Department of (62)
  6. Survivorship Research (62)

More Groups

People
  1. Michael Scordo (45)
  2. Brandon Imber (40)
  3. Maria Palomba (36)
  4. Gunjan Shah (29)
  5. Parastoo Dahi (27)
  6. Connie Batlevi (26)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (14)
  4. 2022 (9)
  5. 2021 (8)
  6. 2020 (8)

More Years

Publications
  1. Blood (18)
  2. Hematological Oncology (10)
  3. International Journal of Radiation Oncology, Biology, Physics (9)
  4. Neuro-Oncology (4)
  5. Blood Advances (3)
  6. Journal of Clinical Oncology (3)

More Publications

Publishers
  1. American Society of Hematology (21)
  2. Elsevier Inc. (15)
  3. Wiley Blackwell (10)
  4. Nature Publishing Group (4)
  5. Oxford University Press (4)
  6. American Society of Clinical Oncology (3)

More Publishers

Results (62)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Highly favorable outcomes with salvage radiation therapy followed by autologous transplant in relapsed and refractory DLBCL patients with minimal or no response to salvage chemotherapy
    Meeting Abstract

    Yang, J. C.; Chau, K.; Scordo, M.; Sauter, C. S.; Yahalom, J.
    Blood (2019)

    Fulltext@MSK | Save
  • High complete response rate observed with second-line chemo-immunotherapy with pembrolizumab and GVD (gemcitabine, vinorelbine, and liposomal doxorubicin) in relapsed and refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G. L.; Schoder, H.; Hancock, H.; Davey, T.; Joong, C.; Pomerantz, L.; Jarjies, C.; Kumar, A.; Lahoud, O. B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Early experience using radiotherapy as a salvage treatment for relapsed or refractory non-Hodgkin lymphomas following CD19 chimeric antigen receptor modified T-cell therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Dahi, P. B.; Sauter, C. S.; Scordo, M.; Batlevi, C. L.; Park, J. H.; Shah, G. L.; Giralt, S. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; Noy, A.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Highly favorable outcomes with RT followed by ASCT in low/low‐intermediate secondary age adjusted IPI rel/ref DLBCL patients refractory to salvage chemotherapy
    Meeting Abstract

    Yang, J. C.; Chau, K. W.; Scordo, M.; Sauter, C. S.; Yahalom, J.
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; DeSelm, C.; Batlevi, C.; Dahi, P. B.; Giralt, S.; Noy, A. M.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Incidence and treatment outcomes of patients with transformed marginal zone lymphoma treated with RCHOP‐like regimens
    Meeting Abstract

    Rajeeve, S.; Bobillo, S. V.; Zelenetz, A. D.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; Moskowitz, A. J.; Hamlin, P. A.; Matasar, M. J.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Lavery, J.; Noy, A.; Palomba, L.; Straus, D. J.; Kumar, A.; Batlevi, C.; Horwitz, S.; Moskowitz, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • The outcome of patients with non-chemosensitive relapsed and refractory DLBCL salvaged with radiation therapy followed by autologous stem cell transplant
    Meeting Abstract

    Yang, J. C.; Chau, K.; Scordo, M.; Sauter, C. S.; Yahalom, J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Patients with relapsed/refractory large cell lymphoma who were also refractory to salvage chemotherapy: Outcome with salvage radiation therapy followed by autologous stem cell transplant
    Meeting Abstract

    Yang, J. C.; Chau, K.; Scordo, M.; Sauter, C. S.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save